Product
Mim8
2 clinical trials
3 indications
Indication
Hemophilia AIndication
Hemophilia A with InhibitorsIndication
Haemophilia AClinical trial
Open-label, Long-term Safety and Efficacy Study of Mim8 in Participants With Haemophilia A With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2028-06-30
Clinical trial
Safety, Efficacy and Exposure of Subcutaneously Administered NNC0365-3769 (Mim8) Prophylaxis in Children With Haemophilia A With or Without FVIII InhibitorsStatus: Recruiting, Estimated PCD: 2025-04-10